Correlation Between Viking Therapeutics and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Virax Biolabs Group, you can compare the effects of market volatilities on Viking Therapeutics and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Virax Biolabs.
Diversification Opportunities for Viking Therapeutics and Virax Biolabs
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Viking and Virax is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Virax Biolabs go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Virax Biolabs
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 0.74 times more return on investment than Virax Biolabs. However, Viking Therapeutics is 1.35 times less risky than Virax Biolabs. It trades about 0.1 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.01 per unit of risk. If you would invest 355.00 in Viking Therapeutics on September 2, 2024 and sell it today you would earn a total of 4,939 from holding Viking Therapeutics or generate 1391.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viking Therapeutics vs. Virax Biolabs Group
Performance |
| Timeline |
| Viking Therapeutics |
| Virax Biolabs Group |
Viking Therapeutics and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Virax Biolabs
The main advantage of trading using opposite Viking Therapeutics and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Viking Therapeutics vs. Tff Pharmaceuticals | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx | Viking Therapeutics vs. Enliven Therapeutics |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |